| Literature DB >> 29069345 |
Stephen F Christy1, Riana I Wernick2, Michael J Lue1, Griselda Velasco1, Dana K Howe2, Dee R Denver2, Suzanne Estes1.
Abstract
A mutation-accumulation (MA) experiment with Caenorhabditis elegans nematodes was conducted in which replicate, independently evolving lines were initiated from a low-fitness mitochondrial electron transport chain mutant, gas-1. The original intent of the study was to assess the effect of electron transport chain dysfunction involving elevated reactive oxygen species production on patterns of spontaneous germline mutation. In contrast to results of standard MA experiments, gas-1 MA lines evolved slightly higher mean fitness alongside reduced among-line genetic variance compared with their ancestor. Likewise, the gas-1 MA lines experienced partial recovery to wildtype reactive oxygen species levels. Whole-genome sequencing and analysis revealed that the molecular spectrum but not the overall rate of nuclear DNA mutation differed from wildtype patterns. Further analysis revealed an enrichment of mutations in loci that occur in a gas-1-centric region of the C. elegans interactome, and could be classified into a small number of functional-genomic categories. Characterization of a backcrossed four-mutation set isolated from one gas-1 MA line revealed this combination to be beneficial on both gas-1 mutant and wildtype genetic backgrounds. Our combined results suggest that selection favoring beneficial mutations can be powerful even under unfavorable population genetic conditions, and agree with fitness landscape theory predicting an inverse relationship between population fitness and the likelihood of adaptation.Entities:
Keywords: adaptation; complex I; electron transport chain; mitochondrial dysfunction; mutation accumulation; sign epistasis
Mesh:
Year: 2017 PMID: 29069345 PMCID: PMC5714194 DOI: 10.1093/gbe/evx222
Source DB: PubMed Journal: Genome Biol Evol ISSN: 1759-6653 Impact factor: 3.416
. 1.—Reproductive schedules. Daily offspring production of N2 (solid line), gas-1 G0 (dashed line, squares), and the combined gas-1 MA lines (dashed line, triangles). Error bars are 1 SEM. Summary statistics are reported in supplementary table S2, Supplementary Material online.
Summary Statistics for Fitness Traits
| N2 | 151.6±10.03 | 1.000±0.053 |
| 38.40±3.277 | 0.225±0.057 | |
| 38.40±3.277 | 1.000±0.085 | |
| 50.58±1.647 | 1.260±0.058 | |
| 127.9±38.20 | 5.757±1.317 | |
| 76.74±84.81 | 0.054±0.059 | |
| 5.191±1.824 | 0.010±0.004 | |
| 628.6±105.7 | 0.014±0.002 | |
| 20.58±1.439 | 0.017±0.001 | |
| −1.547 | −0.004 |
Note.—All values are means ± 1 SEM.
Fitness relative to gas-1 G0; fitness is otherwise reported relative to N2.
W, absolute fitness; ω, relative fitness.
. 2.—Frequency histogram of Histogram of the 48 gas-1 MA lines’ fitness (w) relative to gas-1 G0 (equal to 1.0) using least squares means including the 8 gas-1 MA lines that went extinct.
gas-1 MA Line Mutations
| Position | Type Conversion | Mutation Type | Gene | Classification | Ref Codon | Ref AA | Var Codon | Var AA | Syn or Non | |
|---|---|---|---|---|---|---|---|---|---|---|
| MA412 | II: 11,182,784 | A: T → C: G | A → C | F37H8.3 | Exon | CCA | Pro | CCC | Pro | Syn |
| MA412 | II: 13,912,231 | G: C → A: T | G → A | W02B8.2 | Exon | GAG | Glu | AAG | Lys | Non |
| MA412 | V: 11,394,089 | A: T → G: C | A → G | Intergenic | ||||||
| MA412 | V: 12,318,251 | A: T → C: G | T → G | Intergenic | ||||||
| MA412 | V: 19,920,250 | A: T → G: C | A → G | Intergenic | ||||||
| MA412 | V: 20,674,727 | G: C → T: A | G → T | Exon | TCG | Ser | TCT | Ser | Non | |
| MA412 | X: 5,107,789 | A: T → G: C | T → C | Intergenic | ||||||
| MA412 | X: 6,529,937 | A: T → G: C | T → C | Intergenic | ||||||
| MA412 | X: 10,265,783 | G: C → C: G | G → C | Intergenic | ||||||
| MA419 | III: 896,522 | G: C → T: A | G → T | F23H11.2 | Exon | TGC | Cys | TTC | Phe | Non |
| MA419 | V: 3,152,259 | A: T → T: A | T → A | Intergenic | ||||||
| MA419 | X: 10,274,961 | G: C → A: T | C → T | F41E7.2 | Intron | |||||
| MA419 | X: 4,975,182 | G: C → C: G | G → C | ZC8.6 | Exon | TTC | Phe | TTG | Phe | Syn |
| MA419 | X: 10,368,359 | G: C → T: A | G → T | Intergenic | ||||||
| MA419 | X: 12,384,471 | G: C → A: T | C → T | Intergenic | ||||||
| MA429 | I: 12,870,206 | G: C → A: T | C → T | Intergenic | ||||||
| MA429 | II: 4,663,692 | G: C → A: T | C → T | T05A7.11 | Exon | GCA | Ala | ACA | Thr | Non |
| MA429 | IV: 3,470,137 | G: C → A: T | G → A | F58E2.2 | Exon | AAG | Lys | AAA | Lys | Syn |
| MA429 | X: 17,133,019 | G: C → A: T | C → T | K09E3.7 | Exon | GTG | Vak | ATG | Met | Non |
| MA429 | X: 17,132,998 | A: T → G: C | T → C | K09E3.7 | Exon | ACA | Thr | GCA | Ala | Non |
| MA431 | I: 10,724,831 | A: T → G: C | A → G | Exon | CAT | His | CAC | His | Syn | |
| MA431 | III: 9,455,062 | A: T → T: A | A → T | Intron | ||||||
| MA431 | III: 3,002,544 | G: C → T: A | G → T | Intron | ||||||
| MA431 | III: 4,598,014 | G: C → A: T | C → T | Exon | CGT | Arg | CAT | His | Non | |
| MA431 | IV: 12,986,492 | G: C → A: T | C → T | Intergenic | ||||||
| MA431 | IV: 14,058,054 | A: T → T: A | T → A | Intergenic | ||||||
| MA431 | IV: 17,181,972 | G: C → A: T | G → A | C52D10.3 | Intron | |||||
| MA431 | V: 3,379,498 | G: C → C: G | G → C | C04E12.10 | Exon | GAT | Asp | CAT | His | Non |
| MA431 | X: 5,964,400 | A: T → T: A | T → A | R07E4.1 | Intron | |||||
| MA438 | I: 8,987,554 | G: C → A: T | G → A | Intergenic | ||||||
| MA438 | II: 13,977,894 | G: C → A: T | G → A | Intron | ||||||
| MA438 | III: 2,792,754 | G: C → T: A | G → T | Y71H2AM.24 | Intron | |||||
| MA438 | III: 11,412,255 | A: T → C: G | A → C | Intron | ||||||
| MA438 | IV: 2,620,955 | G: C → A: T | G → A | Intron | ||||||
| MA438 | IV: 7,452,889 | G: C → A: T | G → A | Intergenic | ||||||
| MA438 | V: 14,423,155 | G: C → A: T | C → T | Intergenic | ||||||
| MA438 | V: 1,646,965 | A: T → C: G | A → C | Exon | TGA | Trp | TGC | Cys | Non | |
| MA438 | V: 18,784,124 | A: T → G: C | T → C | Y17D7B.10 | Intron | |||||
| MA438 | X: 9,580,008 | A: T → T: A | A → T | Intergenic | ||||||
| MA438 | X: 17,456,803 | G: C → A: T | G → A | Intergenic |
Ref Allele, reference allele; Var allele, variant allele; Ref Codon, Reference Codon; Ref AA, reference amino acid; Var Codon, variant codon; Var AA, variant amino acid; Syn or Non, synonymous or nonsynonymous mutation.
. 3.—GO slim enrichments and Nonoverlapping sets of GO slims were in enriched in gas-1 (A) and N2 lines (B), which experienced maxima of 47 and 250 generations of mutation accumulation, respectively. (C) Depiction of genes (blue points) predicted to interact within 2-degrees of the gas-1 gene (orange); genes within this network that acquired mutations in one of the five sequenced gas-1 MA lines are shown in pink.
. 4.—Relative fitnesses for MA431 SNP-containing lines and ancestral controls. Fitness of MA431 backcrossed lines relative to N2 reported (mean ± 1 SEM); note the different y-axis scales in each panel: Wilcoxan rank sums tests showed that N2MA431 had improved fitness compared with N2 (χ2(1) = 5.16, P < 0.02) and that gas-1MA431 had improved fitness compared with gas-1 G0 (χ2(1) = 7.34, P < 0.01). (A) Wildtype N2 (1.000 ± 0.021) and N2MA431 (1.065 ± 0.033) and (B) gas-1 G0 (0.068 ± 0.005) and gas-1MA431 (0.097 ± 0.008). * and ** denote statistical significance at P < 0.01 and < 0.05 levels, respectively.